Neuronetics Balance Sheet Health
Financial Health criteria checks 2/6
Neuronetics has a total shareholder equity of $9.4M and total debt of $46.0M, which brings its debt-to-equity ratio to 490.4%. Its total assets and total liabilities are $74.1M and $64.7M respectively.
Key information
490.4%
Debt to equity ratio
US$46.00m
Debt
| Interest coverage ratio | n/a |
| Cash | US$20.87m |
| Equity | US$9.38m |
| Total liabilities | US$64.74m |
| Total assets | US$74.12m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NRC's short term assets ($53.5M) exceed its short term liabilities ($16.9M).
Long Term Liabilities: NRC's short term assets ($53.5M) exceed its long term liabilities ($47.8M).
Debt to Equity History and Analysis
Debt Level: NRC's net debt to equity ratio (267.9%) is considered high.
Reducing Debt: NRC's debt to equity ratio has increased from 57% to 490.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NRC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 4.6% each year